Retraction

RNA interference‑mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.3892/ol.2023.13756
Additional Notes:

see also: https://pubpeer.com/publications/783D49CFB2A516BB7297ACB931F2ED

Citations (41)

41
Total Citations
1
Post-Retraction
(2.4%)
40
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
294 Days since retraction (latest)
The role of USP22 in nucleic acid sensing pathways and interferon-induced necroptotic cell death
Rebekka Karlowitz
Unknown Journal Open Access
Published: Jan 2024
294 days after retraction
The Ubiquitin–Proteasome System and Cerebellar Developmental Disease
Jerry Vriend, Xiaodan Jiao
Contemporary clinical neuroscience
Published: Jan 2023
71 days before retraction
Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis
Mickaël Ohanna, Pierric Biber, Marcel Deckert
Cancers Open Access
Published: Jul 2022
7 citations
245 days before retraction
Clinicopathological and Prognostic Value of USP22 Expression in Gastric Cancer: A Systematic Review and Meta-Analysis and Database Validation
Yuhang Wang, Zirui Jia, Jiacheng Gao et al. (6 authors)
Frontiers in Surgery Open Access
Published: Jun 2022
4 citations
270 days before retraction
Deubiquitinases in Neurodegeneration
Abudu I. Bello, Rituparna Goswami, Shelby L. Brown et al. (8 authors)
Cells Open Access
Published: Feb 2022
26 citations
401 days before retraction
USP22 Mediates High Glucose-Induced Injury and Epithelial-Mesenchymal Transition in Podocytes via Regulating the RIPK3/MLKL Signaling Pathway
Renhua Liu, Weifeng Zhang, Jun Cai et al. (6 authors)
Journal of Hard Tissue Biology Open Access
Published: Jan 2022
1 citation
436 days before retraction
USP22 controls tumorigenicity by regulating interferon responses and the stability of the tumor suppressor PML
Lisa Kowald
Unknown Journal Open Access
Published: Jan 2022
436 days before retraction
The role of ubiquitin-specific peptidases in glioma progression
Wulong Liang, Jia Fang, Shaolong Zhou et al. (10 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Dec 2021
12 citations
441 days before retraction
Potent macrocycle inhibitors of the human SAGA deubiquitinating module
Michael T. Morgan, Tatsuya Ikenoue, Hiroaki Suga et al. (4 authors)
Cell chemical biology Open Access
Published: Dec 2021
25 citations
447 days before retraction
Targeting USP22 with miR‑30‑5p to inhibit the hypoxia‑induced expression of PD‑L1 in lung adenocarcinoma cells
Xiaoyang Hua, Heng Chu, Chuanxiao Wang et al. (6 authors)
Oncology Reports Open Access
Published: Aug 2021
10 citations
581 days before retraction
Potent macrocycle inhibitors of the human SAGA deubiquitinating module
Michael T. Morgan, Tatsuya Ikenoue, Hiroaki Suga et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: May 2021
668 days before retraction
Deubiquitinases: Modulators of Different Types of Regulated Cell Death
Choong-Sil Lee, Seung‐Yeon Kim, Gyuho Hwang et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Apr 2021
15 citations
691 days before retraction
Unraveling the functional relevance of the Ubiquitin-specific peptidase 22 for necroptotic cell death
Jens Rödig
Unknown Journal Open Access
Published: Jan 2021
801 days before retraction
RETRACTED: Knockdown EZH2 attenuates cerebral ischemia-reperfusion injury via regulating microRNA-30d-3p methylation and USP22
Dianshi Jin, Wei Wei, Chong Song et al. (5 authors)
Brain Research Bulletin
Published: Dec 2020
13 citations
802 days before retraction
USP22 controls necroptosis by regulating receptor‐interacting protein kinase 3 ubiquitination
Jens Roedig, Lisa Kowald, Thomas Juretschke et al. (9 authors)
EMBO Reports Open Access
Published: Dec 2020
70 citations
805 days before retraction
Critical Roles of Deubiquitinating Enzymes in the Nervous System and Neurodegenerative Disorders.
Soumyadip Das, Suresh Ramakrishna, Kye-Seong Kim
PubMed
Published: Mar 2020
30 citations
1077 days before retraction
Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α
Guanzhong Qiu, Qiang Liu, Xiaogang Wang et al. (6 authors)
Life Sciences
Published: Feb 2020
19 citations
1122 days before retraction
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
Xue Wen, Sunbin Ling, Weiqiang Wu et al. (10 authors)
Digestive Diseases and Sciences Open Access
Published: Oct 2019
20 citations
1255 days before retraction
Ubiquitin‑specific peptidase 22 promotes proliferation and metastasis in human colon cancer
Xiao Yuan, Hao Wang, Aman Xu et al. (6 authors)
Oncology Letters Open Access
Published: Sep 2019
10 citations
1274 days before retraction
High expression of ubiquitin carboxyl‑terminal hydrolase 22 is associated with poor prognosis in hepatitis B virus‑associated liver cancer
Yong Liao, Xingsi Liang, Wenjin Liang et al. (9 authors)
Oncology Letters Open Access
Published: Mar 2019
3 citations
1459 days before retraction
Targeted Eradication of Gastric Cancer Stem Cells by CD44 Targeting USP22 Small Interfering RNA-Loaded Nanoliposomes
Feng Yang, Zhi Zheng, Xuchao Xue et al. (8 authors)
Future Oncology
Published: Dec 2018
14 citations
1551 days before retraction
Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells
Jun Liang, Xian‐Li Zhang, Shun Li et al. (6 authors)
Cancer Biomarkers
Published: Sep 2018
12 citations
1644 days before retraction
Ubiquitin‐specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell‐specific Moloney murine leukemia virus integration site 1 for stabilization
Guanzhong Qiu, Xiao‐Yuan Mao, Yue Ma et al. (11 authors)
Cancer Science Open Access
Published: May 2018
36 citations
1756 days before retraction
Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer
Lucile M. Jeusset, Kirk J. McManus
Cancers Open Access
Published: Dec 2017
56 citations
1923 days before retraction
The Ubiquitin Proteasome System and Cerebellar Developmental Disease
Jerry Vriend, Xiaodan Jiao
Contemporary clinical neuroscience
Published: Jan 2017
2262 days before retraction
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges
Weilin Jin, Xiao‐Yuan Mao, Guanzhong Qiu
Medicinal Research Reviews
Published: Oct 2016
29 citations
2331 days before retraction
Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma
Huadong Zhao, Haili Tang, Ningning Liu et al. (10 authors)
Oncotarget Open Access
Published: Apr 2016
24 citations
2509 days before retraction
Paper citing Inhibition of δ‑opioid receptors induces brain gli...
Unknown Authors
Unknown Journal
Published: Feb 2016
2594 days before retraction
Dracorhodin perchlorate induces the apoptosis of glioma cells
Xin Chen, Junjie Luo, Linghu Meng et al. (7 authors)
Oncology Reports Open Access
Published: Feb 2016
7 citations
2594 days before retraction
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
Huadong Zhao, Haili Tang, Qike Huang et al. (13 authors)
PubMed
Published: Jan 2016
28 citations
2628 days before retraction
SAGA DUB-Ubp8 Deubiquitylates Centromeric Histone Variant Cse4
Claudia Canzonetta, Stefano Vernarecci, Michele Iuliani et al. (7 authors)
G3 Genes Genomes Genetics Open Access
Published: Dec 2015
25 citations
2657 days before retraction
Usp22 deficiency impairs intestinal epithelial lineage specification <i>in vivo</i>
Robyn Laura Kosinsky, Florian Wegwitz, Nicole Hellbach et al. (8 authors)
Oncotarget Open Access
Published: Sep 2015
33 citations
2726 days before retraction
The deubiquitinating enzyme activity of USP22 is necessary for regulating HeLa cell growth
Yingli Liu, Jie Zheng, Li‐Juan Tang et al. (7 authors)
Gene
Published: Jul 2015
20 citations
2809 days before retraction
MicroRNAs and cell cycle of malignant glioma
Qing Ouyang, Lunshan Xu, Hongjuan Cui et al. (5 authors)
International Journal of Neuroscience
Published: May 2015
39 citations
2852 days before retraction
ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma
Ya-Jing Zhuang, Zhiwei Liao, Hongwei Yu et al. (8 authors)
Cancer Biology & Therapy Open Access
Published: Nov 2014
16 citations
3035 days before retraction
Role of ubiquitin-specific peptidase 22 in carcinogenesis of human pharyngeal squamous cell carcinoma
Yunling Dou, Jia-ping Lin, Haihua Shu et al. (4 authors)
Molecular Medicine Reports Open Access
Published: Sep 2014
9 citations
3094 days before retraction
Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics
Jun Liang, Xianli Zhang, Shao Xie et al. (9 authors)
Medical Oncology
Published: Feb 2014
21 citations
3302 days before retraction
Glioma-Associated Proteases
Petr Bušek, Martin Převorovský, E Kr̆epela et al. (4 authors)
Unknown Journal
Published: Jan 2014
3 citations
3358 days before retraction
Pulling complexes out of complex diseases
Ryan D. Mohan, Susan M. Abmayr, Jerry L. Workman
Rare Diseases Open Access
Published: Jan 2014
9 citations
3358 days before retraction
Spinocerebellar Ataxia
Unknown Authors
SpringerReference
Published: Aug 2011
1 citation
4219 days before retraction
Quick Stats
Total Citations: 41
Years Since Retraction: 2.7 years
Open Access: Yes
Last Checked: Jul 24, 2025